Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-18T20:59:18.119Z Has data issue: false hasContentIssue false

Genes for Alzheimer Dementia

Published online by Cambridge University Press:  18 September 2015

Extract

Alzheimer disease (AD), the most common form of dementia in the elderly, is rapidly becoming a major health problem in developed countries where the number of elderly people continuously grows due to improved medical care. Consequently, the number of AD patients is increasing and thus far no effective therapies are available. Clinically the disease can be diagnosed with 90% reliability on the basis of neurological examination, neuropsychological testing and brain imaging techniques. A definite diagnosis, however, requires the post-mortem detection of senile plaques (SPs) and neurofibrillary tangles (NFTs) in the brain. The SPs are extracellular deposits mainly composed of amyloid P (Ap) surrounded by dystrophic neurites. NFT are intraneural inclusions of paired helical filaments composed of hyperphosphorylated tau.

Although age is the major risk factor for AD, population survey and family studies have provided substantial evidence that genetic factors are major contributors to the expression of AD.

Type
Research Article
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literature

1.De Jonghe, C. Van Broeckhoven, C. Identification and functional Analysis of Genes and genetic Risk Factors in Alzheimer's Disease. In: Molecular-Genetic Techniques for Behavioural Neurosciences. Crusio, WE, Gerlai, R, eds. Amsterdam: Elsevier, 1999; in pressGoogle Scholar
2.Van Broeckhoven, CL. Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur Neurol 1995; 35:819.CrossRefGoogle ScholarPubMed
3.Duijn, CM van, Clayton, DG, Chandra, V, et al.Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. EURODEM Risk Factors Research Group. Genet Epidemiol 1994; 11: 539–51.CrossRefGoogle Scholar
4.Goate, A, Chartier-Harlin, MC, Mullan, M, et al.Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704–6.CrossRefGoogle ScholarPubMed
5.Sherrington, R, Rogaev, EI, Liang, Y, et al.Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754–60.CrossRefGoogle ScholarPubMed
6.Theuns, J, Cruts, M, Del-Favero, J, et al.Determination of the genomic organization of human presenilin 1 by fiber-FISH analysis and restriction mapping of cloned DNA. Mamm Genome 1999; 10: 410–4.CrossRefGoogle ScholarPubMed
7.Cruts, M, Van Broeckhoven, C. Molecular genetics of Alzheimer's disease. Ann Med 1998; 30: 560–5.CrossRefGoogle ScholarPubMed
8.Levy-Lahad, E, Wasco, W, Poorkaj, P, et al.Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973–7.CrossRefGoogle ScholarPubMed
9.Pericak-Vance, MA, Bebout, JL, Gaskell-PC, J, et al.Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J hum Gen 1991; 48: 1034–50.Google ScholarPubMed
10.Pericak-Vance, MA, Bass, MP, Yamaoka, LH, et al.Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997; 278,1237–41.CrossRefGoogle ScholarPubMed
11.Van Broeckhoven, C. Alzheimer's disease: identification of genes and genetic risk factors. Prog Brain Res 1998;117;315–25.CrossRefGoogle ScholarPubMed
12.Wragg, M, Hutton, M, Talbot, C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet 1996;347;509–12.CrossRefGoogle ScholarPubMed